Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A non-invasive brain procedure is turning heads in psychiatry. A new study found that stereotactic radiosurgical (SRS) capsulotomy dramatically reduced suicidal ideation in patients with treatment-resistant major depression — dropping from 70% before the procedure to just 10% afterward. Depression scores also improved significantly, with no neurological side effects reported.
For patients who've exhausted every medication and therapy option, a cutting-edge, incisionless brain procedure may offer new hope. Researchers from the University of South Florida and Tampa General Hospital presented findings on stereotactic radiosurgical (SRS) capsulotomy — a technique that uses precisely targeted radiation to disrupt brain circuits linked to depression — at the annual American Society for Radiation Oncology (ASTRO) meeting.
The study followed 20 patients with treatment-resistant major depressive disorder (trMDD) or intractable OCD with secondary depression, all of whom had failed cognitive behavioral therapy and multiple medications. Over a median follow-up of about 35 months, the results were striking: depression scores dropped significantly, OCD symptoms improved, and cognitive function actually got better — all with no neurological side effects.
By the Numbers:
Why it matters: Treatment-resistant depression affects millions and carries a high risk of suicide. A safe, non-surgical option that delivers lasting relief — with no reported neurological side effects — could be a game-changer for one of psychiatry's most challenging patient populations.
